Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'mcl1 in 1'

Search results for: 'mcl1 in 1'

Items 11-20 of 44

Page
per page
  1. CP-724714
    A2412 CP-724714
    Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1R
    Summary: HER2 inhibitor,potent and selective
      ≥23.5 mg/mL
  2. SB525334
    A5602 SB525334
    Summary: (TGF-beta1) receptor inhibitor
      ≥34.3 mg/mL
  3. R428
    A8329 R428
     10 Citation
    Summary: Selective Axl inhibitor
      ≥25 mg/mL
  4. MK-2461
    A8476 MK-2461
    Target: FLT3|PDGFR|MET|Ron
    Summary: C-Met (WT/mutants) inhibitor
      ≥24.8 mg/mL
  5. R406
    A8546 R406
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and ATP-competitive
      ≥31.45 mg/mL
  6. Ki20227
    A3527 Ki20227
    Target: c-Fms tyrosine kinase
    Summary: C-Fms tyrosine kinase inhibitor
      ≥48.1 mg/mL
  7. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  8. MGCD-265
    A5057 MGCD-265
    Target: VEGFR|c-MET
    Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor
      ≥25.9 mg/mL
  9. AXL1717
    A3209 AXL1717
    Target: Insulin-like growth factor receptors(IGFRs)
    Summary: IGF-1R inhibitor,orally active
      ≥20.7 mg/mL
  10. PD173955
    A8812 PD173955
    Target: Bcr-Abl|Src
    Summary: Dual Src/Abl kinase inhibitor, ATP-competitive,
      ≥22.15 mg/mL

Items 11-20 of 44

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 1 item
  2. Axl 1 item
  3. ALK 3item
  4. c-FMS 1 item
  5. c-Kit 1 item
  6. c-MET 2item
  7. c-RET 2item
  8. CSF-1R 1 item
  9. EGFR 1 item
  10. FGFR 3item
  11. FLT3 4item
  12. HER2 1 item
  13. IGF1R 2item
  14. IRAK 2item
  15. ITK 1 item
  16. LRRK2 2item
  17. PDGFR 6item
  18. Spleen Tyrosine Kinase (Syk) 3item
  19. Src 2item
  20. Tie-2 2item
  21. Trk 1 item
  22. VEGFR 14item
Reversibility
  1. Reversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 3item
  3. Aurora Kinases 1 item
  4. CSF-1R 1 item
  5. FLT3 6item
  6. VEGFR 17item
  7. PDGFR 9item
  8. c-Kit 4item
  9. RET 2item
  10. IRAK 2item
  11. Bcr-Abl 4item
  12. FGFR 3item
  13. Insulin-like growth factor receptors(IGFRs) 1 item
  14. MET 1 item
  15. Src 4item
  16. Trk Receptors 2item
  17. EGFR 2item
  18. BMP and Other Activin Receptors 1 item
  19. JAK 1 item
  20. Syk 3item
  21. c-MET 3item
  22. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  23. LRRK2 2item
  24. Insulin and Insulin-like Receptors 1 item
  25. ALK 1 item
  26. Tie-2 2item
  27. Ron 1 item
  28. c-Fyn 1 item
  29. Insulin Receptors 1 item
  30. IRG-1R 1 item
  31. ZAP-70 1 item
  32. c-Fms tyrosine kinase 1 item
  33. ITK 1 item
  34. DCLK2 1 item
Reported Experiments
  1. Animal Experiments 40item
  2. Cell Experiments 25item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 2item
  6. Breast Cancer 9item
  7. Cancer 27item
  8. Cervical Cancer 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 1 item
  11. Colon Carcinoma 3item
  12. Colorectal Cancer 8item
  13. Glioblastoma 3item
  14. Glioma 1 item
  15. Leukemia 1 item
  16. Liver Cancer 1 item
  17. Lung Cancer 4item
  18. Lung Carcinoma 2item
  19. Lymphoma 2item
  20. Melanoma 1 item
  21. Multiple Myeloma 2item
  22. Myeloma 1 item
  23. Non-small Cell Lung Cancer 3item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 2item
  26. Prostate Cancer 3item
  27. Pulmonary Arterial Hypertension 1 item
  28. Renal Cancer 2item
  29. Renal Cell Carcinoma 2item
  30. Thyroid Cancer 3item